Scarica l'app Stockscreener
0.664
2.50%
-0.017
Dopo l'orario di chiusura:
.66
-0.004
-0.60%
Advanced Biomed Inc Borsa (ADVB) Ultime notizie
advanced biomed enters $25 million stock purchase agreement By Investing.com - Investing.com South Africa
advanced biomed enters $25 million stock purchase agreement - Investing.com Australia
Advanced Biomed Inc. Secures $25 Million Investment Agreement - TipRanks
Advanced Biomed Enters Purchase Agreement With Helena Global - MarketScreener
Pre-market Movers: SHPH, WORX, IOVA, PLRZ... - RTTNews
Advanced Biomed Inc. Announces Board Changes - TipRanks
Bridging Science & Medicine Richter Institute for Medicine of the Future - The Jerusalem Post
GAO sees need for FDA guidance for organ-on-a-chip - BioWorld MedTech
Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study - The Manila Times
Pre-market Movers: LUCY, ALUR, PLRZ, AXDX... - RTTNews
Biomedical Engineering Courses: Admission 2025, Fees, Eligibility, Entrance Exams, Syllabus/Subjects, Top Colleges, Career Scope & Salary - Shiksha
Financing Quarterly Statistics, Q1 2025 - insights.citeline.com
Harbour BioMed Reports Full Year 2024 Financial Results - Yahoo Finance
Mainz enrols first subject in study to evaluate colorectal cancer test - Yahoo Finance
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study - Yahoo Finance
Advanced Instruments to Acquire and Merge with Nova Biomedical - Contract Pharma
Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generation Obesity Therapies - PR Newswire
Advanced Biomed Inc. Completes Successful IPO Launch - TipRanks
Revolutionizing Biomedical Research: Unveiling the Power of Microphysiological Systems with Advanced Assays, Integrated Sensor Technologies, and Real-Time Monitoring - ACS Publications
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket - Benzinga
Red-hot market supports two med-tech IPOs in a day - BioWorld Online
A Dynamic Duo: Travis Stancil and Natella Devitskya Celebrate Five Years of Captivating Performances - The Manila Times
Advanced Biomed Inc. Announces Closing of Initial Public Offering Raising $6.56 Million - Nasdaq
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering - Morningstar
Advanced Biomed prices IPO at $4 per share - MSN
Advanced Biomed Prices 1.6 Million Shares to Raise $6.6 Million in IPO - MarketScreener
OverDrive Appoints Eric Miller to Lead the Company's Data and Information Science Services - The Manila Times
ADVB IPO NewsTaiwanese diagnostics developer Advanced Biomed prices downsized US IPO at the $4 low end - Renaissance Capital
Advanced Biomed Inc. Announces Pricing of Initial Public Offering - GlobeNewswire
This Cancer Detection Biotech Just Priced Its Nasdaq IPOKey Details Inside - StockTitan
Can Mainz Biomed's 82% Detection Rate Technology Revolutionize Colorectal Cancer Prevention? - StockTitan
IPO Roundup: Advanced Biomed, Brag House Holdings and more - MSN
HBM Alpha Therapeutics Enters Strategic Collaboration and License Agreement to Advance Novel Endocrine Therapies - BioSpace
Harbour BioMed and Insilico Medicine Achieve Strategic Collaboration to Advance AI-Driven Antibody Discovery and Development - PR Newswire
Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development - GlobeNewswire
Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population - Yahoo Finance
Moderna Secures $590M Funding From U.S. Government for Bird Flu Jab - Yahoo Finance
NVIDIA Partners With Industry Leaders to Advance Genomics, Drug Discovery and Healthcare - NVIDIA Newsroom
Anaconda Biomed Appoints Trent Reutiman New CEO - Business Wire
Orchestra BioMed shares get shot in the arm on solid clinical trial data - Mugglehead Magazine
Mainz Biomed Enters Agreement with Quest Diagnostics to Advance ColoAlert Colorectal Cancer Screening Test - Nasdaq
Fluid Biomed Inc. Raises $27 Million USD in Oversubscribed Series A Financing to Advance World’s First Bioabsorbable Polymer-Based Stent To Treat Brain Aneurysms - Business Wire
Advanced Biomedical Material Design to Toxicity - ResearchGate
FBB Biomed partners with Verici Dx to advance research on neurologic diseases - Corridor Business Journal
Thermo Fisher Scientific and Mainz Biomed Partner to Advance Colorectal Cancer Screening Technology - citybuzz -
Mainz Biomed Partners with Thermo Fisher to Advance Colorectal Cancer Screening - Contract Pharma
Shire Plans San Diego Campus - Site Selection Magazine
L&K BIOMED Announces FDA Approval of the BluEX Lumbar Expandable Cage System, Featuring Advanced Surface Technology for Comprehensive Spine Interbody Fusion Options. - Becker's Spine Review
Advanced Biomed dramatically downsizes proposed IPO to $9.4M - MSN
1.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):